REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Pharmaplius (Lithuania)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | All Other Business Support Services
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: UAB Pharmaplius Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Pharmaplius is a company in Lithuania, with a head office in Vilnius. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. UAB Pharmaplius was incorporated on August 31, 2016. There are currently 2 (2025) people employed by UAB Pharmaplius. The latest financial highlights indicate a net sales revenue increase of 163.15% in 2024. The enterprise’s net profit margin increased by 5.4% in 2024.

Headquarters
Levandu g. 19
Vilnius; Vilnius county; Postal Code: LT-04123

Contact Details: Purchase the UAB Pharmaplius report to view the information.

Basic Information
Total Employees:
Purchase the UAB Pharmaplius report to view the information.
Registered Capital:
Purchase the UAB Pharmaplius report to view the information.
Financial Auditors:
Purchase the UAB Pharmaplius report to view the information.
Incorporation Date:
August 31, 2016
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Pharmaplius report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
163.15%
Total operating revenue
163.15%
Net Profit (Loss) for the Period
315.99%
Total Equity
64.88%
Net Profit Margin
5.4%
Return on Equity (ROE)
88.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?